Clorox Co. Stock
€93.76
Your prediction
Clorox Co. Stock
Clorox (CLX) is a consumer goods company listed on the New York Stock Exchange. The company is primarily known for its cleaning and disinfecting products, such as bleach and disinfectant wipes, but it also produces other consumer goods such as Glad trash bags and Brita water filters. Clorox operates in several countries and has a strong presence in the United States. The company has a focus on sustainability, with initiatives such as reducing its environmental footprint and promoting responsible sourcing. Clorox has a market capitalization of approximately $22 billion as of August 2021.
Pros and Cons of Clorox Co. in the next few years
Pros
Cons
Performance of Clorox Co. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Clorox Co. | 0.690% | 9.400% | 10.357% | -13.574% | 10.462% | -36.156% | -33.637% |
| International Flavors & Fragrances Inc. | -0.160% | 5.313% | 8.569% | 35.005% | 28.110% | 27.799% | -44.743% |
| Estee Lauder Companies A | 0.560% | 2.692% | 4.308% | -3.154% | -16.989% | -51.217% | -72.992% |
| Kimberly-Clark Corp | 0.400% | 0.139% | -4.916% | -19.978% | 8.887% | -19.544% | -18.066% |
sharewise BeanCounterBot AI-generated
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Clorox (CLX.US) – FY2026 Annual Report
Clorox’s financial position appears to have undergone a dramatic reshaping, with revenue declining to $6.72 billion while the balance sheet more than doubled in size. The company now carries a significantly leveraged profile, and equity attributable to Clorox shareholders has dwindled to just $90 million, pushing the debt‑to‑equity ratio to an extreme level. Profitability has also retreated from the prior year, with net income falling by roughly 28% despite a modest tax benefit, suggesting the year was marked by a major acquisition and operational headwinds.
The revenue trajectory points to a broadening contraction. Overall sales dropped 5.4% year‑on‑year, with the Household and Lifestyle segments each posting double‑digit percentage declines, while the Health and Wellness segment remained flat despite a large acquisition (likely GOJO Industries, judging by the goodwill allocation). Gross margins narrowed from 45.2% to 42.3%, and the net margin fell from 11.4% to 8.7%, erasing much of the improvement seen in the prior year. Rising cost of products sold in Health and Wellness appears to have been a key drag, and interest expense increased 48% as debt ballooned, further compressing the bottom line.
Comments
News
Meet the 5.1%-Yielding Stock That Just Increased Its Dividend for the 49th Consecutive Year. Here's Why It's a Buy in August.
Clorox (NYSE: CLX) investors have had little to smile about lately. If you'd invested $1,000 in Clorox five years ago, you'd have just $621 today. And that's even when factoring in dividends.
But
Clorox Q4 Earnings Call Highlights
Key Points
- Interested in The Clorox Company? Here are five stocks we like better.
- Fiscal 2027 outlook: Clorox expects organic sales to be flat to slightly higher amid muted category growth and
3 Dividend Stocks That Recently Hit 52-Week Lows to Buy in July
When a company is doing well, investors often think the good times will never end and push the stock to shocking highs. When a company is facing difficult times, Wall Street often acts as if the